IP Library Granted Patent US 8,426,159
Granted Patent B2
US 8,426,159 · App. 13/197,654 · Granted Apr 23, 2013

Microfluidic chemostat

Inventors: Frederick Balagadde (Pasadena, CA); Carl L. Hansen (Pasadena, CA); Emil Kartalov (Pasadena, CA); Stephen R. Quake (Stanford, CA)
Assignee: California Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,426,159
App. No.
13/197,654
Granted
Apr 23, 2013
Kind
B2
Abstract

A chemostat is described that includes a growth chamber having a plurality of compartments. Each of the compartments may be fluidly isolated from the rest of the growth chamber by one or more actuatable valves. The chemostat may also include a nutrient supply-line to supply growth medium to the growth chamber, and an output port to remove fluids from the growth chamber. Also, a method of preventing biofilm formation in a growth chamber of a chemostat is described. The method may include the steps of adding a lysis agent to a isolated portion of the growth chamber, and reuniting the isolated portion with the rest of the growth chamber.

Claims (9)

1. A method of preventing biofilm formation in a growth chamber of a chemostat, the method comprising:

isolating a portion of the growth chamber;

adding a lysis agent to the isolated portion of the growth chamber;

flushing the isolated portion with growth medium for a period of time; and

reuniting the isolated portion of the growth chamber with the rest of the growth chamber.

2. The method of claim 1 , wherein isolating a portion of the growth chamber further comprises closing actuable valves that fluidly isolate the portion from the rest of the growth chamber.

3. The method of claim 2 , wherein adding a lysis agent to the isolated portion of the growth chamber further comprises opening an actuable supply valve to supply the lysis agent to the isolated portion of the growth chamber.

4. The method of claim 1 , further comprising removing the lysis agent from the isolated portion of the growth chamber prior to flushing the isolated portion with fresh sterile growth medium.

5. The method of claim 1 , further comprising filling the isolated portion with growth medium prior to reuniting the isolated portion with the rest of the growth chamber.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 22, 2011
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 027437/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2011
From: BALAGADDE, FREDERICK; HANSEN, CARL L.; KARTALOV, EMIL P.; QUAKE, STEPHEN R.
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 026820/0266 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2011
From: ROSEEN, PATRIK
To: ABB RESEARCH LTD.
Reel/Frame 026812/0423 →
Continuity (4)
Continuation 12182088 · Jul 29, 2008
Division 11012852 · Dec 14, 2004
Provisional Application 60536863 · Jan 16, 2004
Related Publication 20120065277A1 · Mar 15, 2012